Because the CellTox Green Dye can be added in a no-step format by adding the dye directly to cells at plating, the CellTox Green Cytotoxicity Assay can be performed prior to the GSH/GSSG-Glo Assay without changes to either protocol
It also supports them as they move to better long-term health
So zooming out: retatrutide is hitting three different hormonal pathwaysreducing appetite (GLP-1), altering how your body uses fuel (GIP), and increasing energy expenditure (glucagon)
The pharmacy, the drug company, PBM? Will Medicare cover obesity treatment? And most importantly: Why were these drugs so expensive in the first place? So todays article is timely, practical, and necessary
What Makes Semaglutide Different Uses a single hormone pathway (GLP-1) to support appetite control Often a great option for patients who prefer a more gradual approach Well-studied with a long track record in metabolic care What Makes Tirzepatide Different Activates two hormone pathways (GLP-1 and GIP) for broader metabolic support May provide stronger appetite suppression for some patients Often considered for patients who need additional metabolic support or have experienced plateaus What Clinical Trials Show GLP-1s Can Do The Proof in the Data Semaglutide By week 68, 86.4% lost at least 5%, 69.1% lost at least 10%, and 50.5% lost at least 15%